Insider trade

Tenet Health (THC)Officer sold ~$1.12M

Thomas W Arnst, Officer at Tenet Health, sold ~$1.12M of Tenet Health shares.

~$1.12M
Approx. value · 4,714 sh @ $238.42
3,298
Holds after · shares reported
Traded
Mar 9, 2026
Filed
Mar 11, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Dec 10, 2025CongressDisclosed purchase of THC — reported range $15,001 - $50,000
  2. Jan 27, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors (and 1 more item)
  3. Feb 3, 2026Federal contract · $135K obligatedDepartment of Veterans Affairs awarded TENET HEALTHCARE CORP: $135K obligated to date
  4. Feb 11, 2026Company filing · Form 8-K · ResultsReported its results
  5. Feb 11, 2026CongressDisclosed partial sale of THC — reported range $1,001 - $15,000
  6. Mar 2, 2026Insider · 2 peopleInsiders: 4 sales (~$7.5M)
  7. Mar 9, 2026 · this disclosureInsiderOfficer sold ~$1.12M of THC shares in the open market

What came next

  1. Mar 9, 2026InsiderOfficer sold ~$787K of THC shares in the open market
  2. Mar 11, 2026Insider · Named in an 8-K 29 days laterOfficer sold ~$1.55M of THC shares in the open market
  3. Mar 25, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On March 25, 2026 , the Company appointed J. Michael Grooms, age 48, Senior Vice President & Controller of the Company, effective April 6, 2026. Mr. Grooms will succeed Mr. Ramsey as the Company’s Principal Accounting Officer effective May 1, 2026, following the effective date of Mr. Ramsey’s retirement.”
  4. Mar 31, 2026Federal contract · $350K obligatedDepartment of Defense awarded TENET HEALTHCARE CORP: $350K obligated to date
  5. Apr 9, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On April 9, 2026 , Tenet Healthcare Corporation (the “Company”) and Paola Arbour entered into a Retirement Transition Agreement and General Release (the “Agreement”) that provides that Ms. Arbour will retire from her role as Executive Vice President and Chief Information Officer effective December 31, 2026, but will remain employed on a part-time basis in a non-executive role through April 1, 2028 to provide…”
  6. Apr 15, 2026CongressDisclosed sale of THC — reported range $1,001 - $15,000
  7. Apr 20, 2026CongressDisclosed sale of THC — reported range $15,001 - $50,000
  8. Apr 30, 2026Company filing · Form 8-K · ResultsReported its results
  9. May 27, 2026InsiderDirector sold ~$532K of THC shares in the open market
  10. May 28, 2026Insider · 1 personInsiders: 5 sales (~$984K)
  11. Jun 12, 2026Federal contract · $135K obligatedDepartment of Veterans Affairs awarded TENET HEALTHCARE CORP: $135K obligated to date
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Tenet Health

For Tenet Health, OQRO holds 19 insider filings (SEC Form 4 or Form 144) and 10 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its THC page.

Other recent filings by Thomas W Arnst, EVP, Chief Admin. Officer & GC

The full history of Thomas W Arnst, EVP, Chief Admin. Officer & GC is on the profile page.

How this filing works

Other disclosures at Tenet Health

Everything OQRO holds on this company is on its THC page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data